India Active Pharmaceutical Ingredients Market, by Product Type (Low Potent APIs and High Potent APIs), by Molecule Type (Acetaminophen, Naproxen, Dextromethorphan Hydrobromide, Gabapentin, Ciprofloxacin, Ofloxacin, Mirtazapine, Sotalol, Levetiracetam, Salmeterol, Salbutamol, Fexuprazan, Diclofenac, Azithromycin, Afatinib dimaleate, Apixaban, Bendamustine, Bosentan Monohydrate, Atorvastin Calcium, Atorvastin Calcium, Ibuprofen, Praziquantel, Oseltamivir - Process A, Lanthanum Carbonate Octa, Sevelamer Carbonate, Succinyl Choline Chloride, and Others), by Formulation (Oral, Topical, Injectables, and Drops), by Application (Diabetes, Oncology, Cardiovascular, CNS, Analgesics, Dermatology, Respiratory, Opthalmic, and Others), and by Region (North India, South India, East India, West India, and Central India) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
The active pharmaceutical ingredient (API) in a medication is the component that causes the desired effects. Active pharmaceutical ingredients are mostly manufactured at big manufacturing factories and its manufacturing process involves a series of operations such as multi-step chemical synthesis, fermentation, purification, crystallization, drying, milling, packing, labeling, and testing. They may also be examined by foreign government agencies, and third-party corporations may conduct audits at API facilities. APIs must meet the quality and safety requirements imposed by the producing country. Even if the production is outsourced, API businesses must adhere to the rigorous requirements of the relevant health authorities. Most of the active pharmaceutical ingredient companies are headquartered in India. However, because the bulk API production takes place in mostly Asian countries such as China, they are the source of the majority of APIs produced worldwide.
Market Dynamics
The active pharmaceutical ingredients manufacturers are starting production units in India to remain competitive and gain benefit over other competitors, which is projected to fuel the market growth during the forecast period. For instance, in February 2017, Nacto pharma, an Indian multinational pharmaceutical company, planned to invest around US$ 1 Billion and expand its active pharmaceutical ingredient (API) and intermediates manufacturing facility in Tamil Nadu.
Key features of the study:
This report provides an in-depth analysis of the India active pharmaceutical ingredient market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the India active pharmaceutical ingredients market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Salora, Aurobindo Pharma Limited, Dr. Reddy's Laboratories, Lupin Limited, Sun Pharmaceutical Industries Limited, Divi’s Laboratories Ltd., Aarti Drugs Ltd., Hikal Ltd., Neuland Labs, Century Pharmaceuticals Ltd., Proventus Life Sciences Pvt Ltd, Chiral Drugs Pvt Ltd, USV Private Limited, and ASolution Pharmaceuticals Pvt. Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The India active pharmaceutical ingredient market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the India active pharmaceutical ingredient market
Detailed Segmentation:
India Active Pharmaceutical Ingredient Market, By Product Type:
Low Potent APIs
High Potent APIs
India Active Pharmaceutical Ingredient Market, By Molecular Type:
Acetaminophen
Naproxen
Dextromethorphan Hydrobromide
Gabapentin
Ciprofloxacin
Ofloxacin
Mirtazapine
Sotalol
Levetiracetam
Salmeterol
Salbutamol
Fexuprazan
Diclofenac
Azithromycin
Afatinib dimaleate
Apixaban
Bendamustine
Bosentan Monohydrate
Atorvastin Calcium
Atorvastin Calcium
Ibuprofen
Praziquantel
Oseltamivir - Process A
Lanthanum Carbonate Octa
Sevelamer Carbonate
Succinyl Choline Chloride
Others
India Active Pharmaceutical Ingredient Market, By Formulation:
Oral
Topical
Injectables
Drops
India Active Pharmaceutical Ingredient Market, By Application:
Diabetes
Oncology
Cardiovascular
CNS
Analgesics
Dermatology
Respiratory
Ophthalmic
Others
India Active Pharmaceutical Ingredient Market, By Region:
North India
By Product Type
Low Potent APIs
High Potent APIs
By Molecular Type
Acetaminophen
Naproxen
Dextromethorphan Hydrobromide
Gabapentin
Ciprofloxacin
Ofloxacin
Mirtazapine
Sotalol
Levetiracetam
Salmeterol
Salbutamol
Fexuprazan
Diclofenac
Azithromycin
Afatinib dimaleate
Apixaban
Bendamustine
Bosentan Monohydrate
Atorvastin Calcium
Atorvastin Calcium
Ibuprofen
Praziquantel
Oseltamivir - Process A
Lanthanum Carbonate Octa
Sevelamer Carbonate
Succinyl Choline Chloride
Others
By Formulation
Oral
Topical
Injectables
Drops
By Application
Diabetes
Oncology
Cardiovascular
CNS
Analgesics
Dermatology
Respiratory
Ophthalmic
Others
By States
Delhi
Uttar Pradesh
Rajasthan
Punjab
Others
South India
By Product Type
Low Potent APIs
High Potent APIs
By Molecular Type
Acetaminophen
Naproxen
Dextromethorphan Hydrobromide
Gabapentin
Ciprofloxacin
Ofloxacin
Mirtazapine
Sotalol
Levetiracetam
Salmeterol
Salbutamol
Fexuprazan
Diclofenac
Azithromycin
Afatinib dimaleate
Apixaban
Bendamustine
Bosentan Monohydrate
Atorvastin Calcium
Atorvastin Calcium
Ibuprofen
Praziquantel
Oseltamivir - Process A
Lanthanum Carbonate Octa
Sevelamer Carbonate
Succinyl Choline Chloride
Others
By Formulation
Oral
Topical
Injectables
Drops
By Application
Diabetes
Oncology
Cardiovascular
CNS
Analgesics
Dermatology
Respiratory
Ophthalmic
Others
By States
Tamil Nadu
Kerala
Andhra Pradesh
Telangana
Others
East India
By Product Type
Low Potent APIs
High Potent APIs
By Molecular Type
Acetaminophen
Naproxen
Dextromethorphan Hydrobromide
Gabapentin
Ciprofloxacin
Ofloxacin
Mirtazapine
Sotalol
Levetiracetam
Salmeterol
Salbutamol
Fexuprazan
Diclofenac
Azithromycin
Afatinib dimaleate
Apixaban
Bendamustine
Bosentan Monohydrate
Atorvastin Calcium
Atorvastin Calcium
Ibuprofen
Praziquantel
Oseltamivir - Process A
Lanthanum Carbonate Octa
Sevelamer Carbonate
Succinyl Choline Chloride
Others
By Formulation
Oral
Topical
Injectables
Drops
By Application
Diabetes
Oncology
Cardiovascular
CNS
Analgesics
Dermatology
Respiratory
Ophthalmic
Others
By States
Bihar
Jharkhand
West Bengal
Others (North East India)
West India
By Product Type
Low Potent APIs
High Potent APIs
By Molecular Type
Acetaminophen
Naproxen
Dextromethorphan Hydrobromide
Gabapentin
Ciprofloxacin
Ofloxacin
Mirtazapine
Sotalol
Levetiracetam
Salmeterol
Salbutamol
Fexuprazan
Diclofenac
Azithromycin
Afatinib dimaleate
Apixaban
Bendamustine
Bosentan Monohydrate
Atorvastin Calcium
Atorvastin Calcium
Ibuprofen
Praziquantel
Oseltamivir - Process A
Lanthanum Carbonate Octa
Sevelamer Carbonate
Succinyl Choline Chloride
Others
By Formulation
Oral
Topical
Injectables
Drops
By Application
Diabetes
Oncology
Cardiovascular
CNS
Analgesics
Dermatology
Respiratory
Ophthalmic
Others
By States
Maharashtra
Goa
Gujarat
Central India
By Product Type
Low Potent APIs
High Potent APIs
By Molecular Type
Acetaminophen
Naproxen
Dextromethorphan Hydrobromide
Gabapentin
Ciprofloxacin
Ofloxacin
Mirtazapine
Sotalol
Levetiracetam
Salmeterol
Salbutamol
Fexuprazan
Diclofenac
Azithromycin
Afatinib dimaleate
Apixaban
Bendamustine
Bosentan Monohydrate
Atorvastin Calcium
Atorvastin Calcium
Ibuprofen
Praziquantel
Oseltamivir - Process A
Lanthanum Carbonate Octa
Sevelamer Carbonate
Succinyl Choline Chloride
Others
By Formulation
Oral
Topical
Injectables
Drops
By Application
Diabetes
Oncology
Cardiovascular
CNS
Analgesics
Dermatology
Respiratory
Ophthalmic
Others
By States
Madhya Pradesh
Chhattisgarh
Company Profiles
Teva Pharmaceutical Industries Ltd *
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
Salora
Aurobindo Pharma Limited
Dr. Reddy's Laboratories
Lupin Limited
Sun Pharmaceutical Industries Limited
Divi’s Laboratories Ltd.
Aarti Drugs Ltd.
Hikal Ltd.
Neuland Labs
Century Pharmaceuticals Ltd.
Proventus Life Sciences Pvt Ltd
Chiral Drugs Pvt Ltd
USV Private Limited
ASolution Pharmaceuticals Pvt. Ltd.
“*” marked represents similar segmentation in other categories in the respective section.
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Molecule Type
- Market Snapshot, By Formulation
- Market Snapshot, By Application
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Pipeline Analysis
- Regulatory Scenario
- Market Trends
- Key Developments
- Epidemiology
- PEST Analysis
- Brand Analysis
- 4. India Active Pharmaceutical Ingredients Market– Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply and Demand Analysis
- Key Developments
- 5. India Active Pharmaceutical Ingredients Market, By Product Type, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- High Potent APIs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Low Potent APIs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- 6. India Active Pharmaceutical Ingredients Market, By Molecule Type, By , 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Acetaminophen
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Naproxen
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Dextromethorphan Hydrobromide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Ciprofloxacin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Ofloxacin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Mirtazapine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Sotalol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Levetiracetam
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Salmeterol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Salbutamol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Fexuprazan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Diclofenac
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Pantoprazole
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Azithromycin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Afatinib dimaleate
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Apixaban
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Bendamustine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Bosentan Monohydrate
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Atorvastin Calcium
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Ibuprofen
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Gabapentin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Praziquantel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Oseltamivir - Process A
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Lanthanum Carbonate OCTA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Sevelamer Carbonate
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Succinyl Choline Chloride
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- 7. India Active Pharmaceutical Ingredients Market, By Formulation, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Injectables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Drops
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- 8. India Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Cardiovascular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- CNS
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Dermatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Respiratory
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Ophthalmic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- 9. India Active Pharmaceutical Ingredients Market, By Region, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- North India
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- South India
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- East India
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- West India
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Central India
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- 10. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Solara
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Aurobindo Pharma Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Dr. Reddy's Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lupin Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sun Pharmaceutical Industries Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Divi’s Laboratories Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Aarti Drugs Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Hikal Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Neuland Labs
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Century Pharmaceuticals Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Proventus Life Sciences Pvt Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Chiral Drugs Pvt Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- USV Private Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- ASolution Pharmaceuticals Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
- 11. Section
- Research Methodology
- About us
- *Browse 28 market data tables and 34 figures on "India Active Pharmaceutical Ingredient Market” - forecast to 2028
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook